* Precigen Inc PGEN.OQ PGEN.O is expected to show a fall
in
quarterly revenue when it reports results on November 7
(estimated) for the period ending September 30 2024
* The Germantown Maryland-based company is expected to
report a
9.4% decrease in revenue to $1.25 million from $1.38 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Precigen Inc is for a
loss
of 8 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Precigen
Inc is
7.00, above its last closing price of $0.82.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.10 -0.10 -0.10 Met -3.7
Jan. 1 2024 -0.09 -0.09 -0.10 Missed -14.2
Jan. 1 0001 -0.08 -0.13 Missed -67.7
Sep. 30 2023 -0.08 -0.08 -0.08 Met -2.6
Jun. -0.10 -0.10 -0.08 Beat 20
30 2023
Mar. 31 2023 -0.10 -0.09 -0.10 Missed -9.6
Dec. 31 2022 -0.10 -0.10 -0.11 Missed -10
Sep. 30 2022 0.00 0.02 -0.04 Missed -340
This summary was machine generated November 6 at 13:59 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)